American Riviera sees net income fall in 2024
Santa Barbara-based American Riviera Bank saw net income take a slight dip to end the fiscal year. Announced Jan. 24, ARB noted net income of $8.7 million for the year, down from net income of $10.2 million in 2023. In the fourth quarter of 2024, American Riviera had $2 million in net income, down from Read More →
Teledyne finishes fiscal year strong with record Q4
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Calavo ends fiscal year strong, maintains focus on ‘core avocado business’
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Strong avocado sales drive revenue growth for ag companies
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Strong quarter from Inogen helps stock climb double digits
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
The Trade Desk shares gain back 12% loss in week after earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind keeps hitting higher revenues
Westlake Village-based MannKind saw rising revenue and gave a positive update to its orphan lung pipeline when it announced its earnings for the third quarter of 2024. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, announced that revenue for the quarter ended Sept. 30 hit $70.1 million, up from $51.2 Read More →
